Cargando…
Quality evaluation of investigator‐initiated trials using post‐approval cancer drugs in Japan
Investigator‐initiated trials (IIT) are important aspects of medical research and have contributed substantially to modern oncology. IIT using post‐approval drugs have been conducted by domestic institutions in Japan. Data from the present study were obtained by all IIT registered clinical trials fo...
Autores principales: | Kondo, Shunsuke, Hosoi, Hiroko, Itahashi, Kota, Hashimoto, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448621/ https://www.ncbi.nlm.nih.gov/pubmed/28266163 http://dx.doi.org/10.1111/cas.13223 |
Ejemplares similares
-
A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States
por: Hoshino, Yuko, et al.
Publicado: (2022) -
Lifecycle management of orphan drugs approved in Japan
por: Seki, Kiyoshi, et al.
Publicado: (2022) -
Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017) -
Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan
por: Kubota, Sachie, et al.
Publicado: (2016) -
Exploratory analysis of comparative clinical trials used for marketing approval in patients with type 2 diabetes in Japan
por: Kaneko, Reina, et al.
Publicado: (2019)